$71.4 Million available via Pharmaceutical Benefit Plan Settlements Overview There are typically several active lawsuits and/or class...

Updated: June 2022 IN RE: GENERIC PHARMACEUTICALS PRICING ANTITRUST LITIGATION Summary Drug-makers of all sizes face allegations from the...

Updated: August 2022 IN RE: NATIONAL PRESCRIPTION OPIATE LITIGATION Case Overview Entities in every link in the chain of opioid drug...